BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, FY2025
4,361
Period ended Dec 31, 2025
Change on a year earlier
+30.9%
3,332 in FY2024
History
13 years
Since FY2013
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total shareholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,361 | +30.9% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 3,332 | -5.8% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 3,537 | -19.3% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 4,383 | -28.5% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 6,133 | +61.2% | Form 10-Q (filed 2022-11-09) ↗ |
| FY2020 | Dec 31, 2020 | 3,803 | +304.4% | Form 10-Q (filed 2022-11-09) ↗ |
| FY2019 | Dec 31, 2019 | 941 | -46.4% | Form 10-K (filed 2023-02-27) ↗ |
| FY2018 | Dec 31, 2018 | 1,754 | +156.3% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | 684 | +93.9% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 353 | -446.7% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | -102 | +92.1% | Form 10-Q (filed 2016-05-12) ↗ |
| FY2014 | Dec 31, 2014 | -53 | +43.2% | Form 10-K (filed 2017-03-22) ↗ |
| FY2013 | Dec 31, 2013 | -37 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Total shareholders' equity ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_eq
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.